Surface Logix
Brighton
About Surface Logix
Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $100.9M
- Funding stage: M&A
- Last round: Series Unknown (Jul 2010)
- Website: surfacelogix.com
- Phone: (617)746-8500
Industries & Categories
Biopharma, Biotechnology, Health Care
Canonical: https://fsome.com/organization/surface-logix-2890985 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.